Frédéric Colland
Impact in
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways
- Cell death mechanisms and regulation
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Aging top 5%
Papers in
-
- Ubiquitin and proteasome pathways 17
- Histone Deacetylase Inhibitors Research 6
- Protein Degradation and Inhibitors 4
- Cell death mechanisms and regulation 4
- TGF-β signaling in diseases 3
- Oncology 7
- Cancer-related Molecular Pathways 5
- Co-authors
- Laurent Daviet (5 shared papers)Madelon M. Maurice (3 shared papers)Wolfgang Sippl (4 shared papers)Annie Kolb (4 shared papers)Vincent Collura (3 shared papers)Niels van den Broek (1 shared paper)Alida M.M. de Vries-Smits (1 shared paper)Armando van der Horst (1 shared paper)
- Journals
- Molecular Microbiology (3 papers)The EMBO Journal (3 papers)Nature Cell Biology (2 papers)Biochimie (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Frédéric Colland
39 papers receiving 3.9k citations
Frédéric Colland's Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Biology 3.1k
- Aging 77
- Oncology 1000
- Hematology 353
- Immunology 468
Countries citing papers authored by Frédéric Colland
This map shows the geographic impact of Frédéric Colland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Colland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Colland more than expected).
Fields of papers citing papers by Frédéric Colland
This network shows the impact of papers produced by Frédéric Colland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Colland. The network helps show where Frédéric Colland may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Colland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models Hit paper breakdown → | 2016 | 870 |
| 2 | 2006 | 407 | |
| 3 | 2009 | 288 | |
| 4 | 2012 | 237 | |
| 5 | 2017 | 154 | |
| 6 | 2018 | 146 | |
| 7 | 2009 | 129 | |
| 8 | 2007 | 128 | |
| 9 | 2010 | 111 | |
| 10 | 2015 | 107 | |
| 11 | 2010 | 104 | |
| 12 | 2007 | 99 | |
| 13 | 2018 | 96 | |
| 14 | 2005 | 93 | |
| 15 | 2010 | 92 | |
| 16 | 1998 | 87 | |
| 17 | 2020 | 86 | |
| 18 | 2000 | 79 | |
| 19 | 2001 | 71 | |
| 20 | 2015 | 67 |
About Frédéric Colland
Frédéric Colland is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Genetics, having authored 39 papers that have together received 4.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (17 papers), Histone Deacetylase Inhibitors Research (6 papers), Bacterial Genetics and Biotechnology (5 papers), Cancer-related Molecular Pathways (5 papers), Protein Degradation and Inhibitors (4 papers), Cell death mechanisms and regulation (4 papers), TGF-β signaling in diseases (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Molecular Biology (3.1k citations), Aging (77 citations), Oncology (1000 citations), Hematology (353 citations) and Immunology (468 citations). Frédéric Colland has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Laurent Daviet, Madelon M. Maurice, Wolfgang Sippl, Annie Kolb, Vincent Collura, Niels van den Broek, Alida M.M. de Vries-Smits, Armando van der Horst, Boudewijn M.T. Burgering and Arjan B. Brenkman. Their work appears in journals such as Molecular Microbiology, The EMBO Journal, Nature Cell Biology, Biochimie and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.